Murphy DL - Search Results

1

A pilot placebo-controlled study of chronic m-CPP administration in Alzheimer's disease.

Lawlor BA, Sunderland T, Mellow AM, Molchan SE, Martinez R, Murphy DL. Lawlor BA, et al. Among authors: murphy dl. Biol Psychiatry. 1991 Jul 15;30(2):140-4. doi: 10.1016/0006-3223(91)90167-k. Biol Psychiatry. 1991. PMID: 1912105 Free article. Clinical Trial.

2

Plasma levels of m-chlorophenylpiperazine following single oral dose administration of m-chlorophenylpiperazine and trazodone in human volunteers.

Lawlor BA, Radcliffe J, Martinez R, Sunderland T, Murphy DL. Lawlor BA, et al. Among authors: murphy dl. Biol Psychiatry. 1997 Mar 15;41(6):756-7. doi: 10.1016/S0006-3223(96)00521-5. Biol Psychiatry. 1997. PMID: 9067003 Clinical Trial. No abstract available.

3

Physiologic and neuroendocrine responses to intravenous naloxone in subjects with Alzheimer's disease and age-matched controls.

Tariot PN, Upadhyaya A, Sunderland T, Cox C, Cohen RM, Murphy DL, Loy R. Tariot PN, et al. Among authors: murphy dl. Biol Psychiatry. 1999 Aug 1;46(3):412-9. doi: 10.1016/s0006-3223(98)00329-1. Biol Psychiatry. 1999. PMID: 10435208 Free article. Clinical Trial.

4

Hyperresponsivity to the serotonin agonist m-chlorophenylpiperazine in Alzheimer's disease. A controlled study.

Lawlor BA, Sunderland T, Mellow AM, Hill JL, Molchan SE, Murphy DL. Lawlor BA, et al. Among authors: murphy dl. Arch Gen Psychiatry. 1989 Jun;46(6):542-9. doi: 10.1001/archpsyc.1989.01810060064010. Arch Gen Psychiatry. 1989. PMID: 2730278 Clinical Trial.

5

A preliminary study of the effects of intravenous m-chlorophenylpiperazine, a serotonin agonist, in elderly subjects.

Lawlor BA, Sunderland T, Mellow AM, Hill JL, Newhouse PA, Murphy DL. Lawlor BA, et al. Among authors: murphy dl. Biol Psychiatry. 1989 Mar 15;25(6):679-86. doi: 10.1016/0006-3223(89)90237-0. Biol Psychiatry. 1989. PMID: 2923931

6

Effects of daily oral m-chlorophenylpiperazine in elderly depressed patients. Initial experience with a serotonin agonist.

Mellow AM, Lawlor BA, Sunderland T, Mueller EA, Molchan SE, Murphy DL. Mellow AM, et al. Among authors: murphy dl. Biol Psychiatry. 1990 Oct 1;28(7):588-94. doi: 10.1016/0006-3223(90)90396-j. Biol Psychiatry. 1990. PMID: 2223928 Free article. Clinical Trial.

7

A preliminary study of the effects of nighttime administration of the serotonin agonist, m-CPP, on sleep architecture and behavior in healthy volunteers.

Lawlor BA, Newhouse PA, Balkin TJ, Molchan SE, Mellow AM, Murphy DL, Sunderland T. Lawlor BA, et al. Among authors: murphy dl. Biol Psychiatry. 1991 Feb 1;29(3):281-6. doi: 10.1016/0006-3223(91)91290-8. Biol Psychiatry. 1991. PMID: 2015332 Free article. Clinical Trial.

8

A pilot study of serotonergic system responsivity in Alzheimer's disease.

Lawlor BA, Mellow AM, Sunderland T, Hill JL, Murphy DL. Lawlor BA, et al. Among authors: murphy dl. Psychopharmacol Bull. 1988;24(1):127-9. Psychopharmacol Bull. 1988. PMID: 3290935 Clinical Trial. No abstract available.

9

Thyroid disease and dementia of the Alzheimer type.

Lawlor BA, Sunderland T, Mellow AM, Murphy DL. Lawlor BA, et al. Among authors: murphy dl. Am J Psychiatry. 1988 Apr;145(4):533-4. doi: 10.1176/ajp.145.4.533b. Am J Psychiatry. 1988. PMID: 3348464 No abstract available.

10

Naloxone and Alzheimer's disease. Cognitive and behavioral effects of a range of doses.

Tariot PN, Sunderland T, Weingartner H, Murphy DL, Cohen MR, Cohen RM. Tariot PN, et al. Among authors: murphy dl. Arch Gen Psychiatry. 1986 Aug;43(8):727-32. doi: 10.1001/archpsyc.1986.01800080013002. Arch Gen Psychiatry. 1986. PMID: 3729666 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

893 results

Search Page

Filters